Several new optical imaging agents targeting specific cell surface markers, such as HER2 receptor (48), have been reported, but these specific cellular markers may or may not be expressed on all cancer cells and are only related to tumors expressing these biomarkers on the cell surface (only 15–20% for HER2). Here, ERBB2 is linked to cancer.